Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells
Open Access
- 20 November 2017
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (1) , 207-218
Abstract
Synovial sarcoma (SS) is an aggressive soft-tissue sarcoma that is often discovered during adolescence and young adulthood. Despite the name, synovial sarcoma does not typically arise from a synoviocyte but instead arises in close proximity to bones. Previous work demonstrated that mice expressing the characteristic SS18-SSX fusion oncogene in myogenic factor 5–expressing (Myf5-expressing) cells develop fully penetrant sarcomagenesis, suggesting skeletal muscle progenitor cell origin. However, Myf5 is not restricted to committed myoblasts in embryos but is also expressed in multipotent mesenchymal progenitors. Here, we demonstrated that human SS and mouse tumors arising from SS18-SSX expression in the embryonic, but not postnatal, Myf5 lineage share an anatomic location that is frequently adjacent to bone. Additionally, we showed that SS can originate from periosteal cells expressing SS18-SSX alone and from preosteoblasts expressing the fusion oncogene accompanied by the added stabilization of β-catenin, which is a common secondary change in SS. Expression and secretion of the osteoclastogenesis inhibitory factor osteoprotegerin enabled early growth of SS18-SSX2–transformed cells, indicating a paracrine link between the bone and synovial sarcomagenesis. These findings explain the skeletal contact frequently observed in human SS and may provide alternate means of enabling SS18-SSX–driven oncogenesis in cells as differentiated as preosteoblasts.Keywords
Funding Information
- National Cancer Institute (R01CA2013956)
- National Cancer Institute (P30CA042014)
- Sarcoma Foundation of America (2011)
- Paul Nabil Bustany Memorial Fund for Synovial Sarcoma Research (2009-2017)
- Damon Runyon Cancer Research Foundation (Clinical Investigator Award 2012-2015)
- Huntsman Cancer Foundation (2008-2017)
This publication has 46 references indexed in Scilit:
- Osteoblast migration into type I collagen gel and differentiation to osteocyte-like cells within a self-produced mineralized matrix: A novel system for analyzing differentiation from osteoblast to osteocyteBone, 2013
- Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood VesselsDevelopmental Cell, 2010
- Multiple functions of Osterix are required for bone growth and homeostasis in postnatal miceProceedings of the National Academy of Sciences, 2010
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyNature Genetics, 2010
- Two Cell Lineages, myf5 and myf5-Independent, Participate in Mouse Skeletal MyogenesisDevelopmental Cell, 2008
- Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast DifferentiationDevelopmental Cell, 2005
- Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline inductionNucleic Acids Research, 2005
- Mouse α1(I)‐collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblastDevelopmental Dynamics, 2002
- Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin geneThe EMBO Journal, 1999
- Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location.American Journal of Roentgenology, 1995